Gene therapy in gynecological cancer.
Gynecological malignancies remain a major source of morbidity and mortality worldwide. In the USA alone, more than 77,000 women are diagnosed annually and over 28,000 die of some form of a gynecological malignancy. Many of these women will fail conventional therapy, leaving few remaining treatment options. Gene therapy presents one possible alternative treatment modality although, unfortunately, it is currently more theoretical than practical. Here, some of the basic science behind gene therapy is reviewed, different delivery systems used to transport the therapeutic gene are discussed, different methods of achieving a therapeutic effect are examined, some of the key trials in ovarian, endometrial, cervical and vulvar cancer research are highlighted and the future of gene therapy is explored.
Brooks
Rebecca A
RA
Department of Obstetrics and Gynecology, Washington University, St. Louis, MO, USA. brooksr@wudosis.wustl.edu
Mutch
David G
DG
D002471:Cell Transformation, Neoplastic / Q000235:genetics; D005260:Female; D018014:Gene Transfer Techniques; D020022:Genetic Predisposition to Disease; D015316:Genetic Therapy / Q000379:methods / Q000639:trends; D005833:Genital Neoplasms, Female / Q000235:genetics* / Q000628:therapy*; D006801:Humans